Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001013594-25-001417·ACHIEVE LIFE SCIENCES, INC.
Schedule 13G ownership disclosure
Achieve Life Sciences Inc
Common Stock, par value $0.001 per share · CUSIP: 004468500
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Contrarian Alpha, LP
Shares: 550,000 · Class: 1.1%
- Contrarian Achieve SPV, LP
Shares: 1,978,377 · Class: 3.8%
- Contrarian Achieve GP LLC
Shares: 1,978,377 · Class: 3.8%
- Contrarian Alpha GP, LLC
Shares: 550,000 · Class: 1.1%
- Contrarian Alpha Management, LLC
Shares: 550,000 · Class: 1.1%
- Parker Quillen
Shares: 2,528,377 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-25-001417
- Form type
- SCHEDULE 13G/A
- Filer
- ACHIEVE LIFE SCIENCES, INC.
- CIK
- CIK 949858
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership